WallStSmart

Marex Group plc Ordinary Shares (MRX)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 66266% more annual revenue ($2.17T vs $3.27B). NMR leads profitability with a 16.7% profit margin vs 10.6%. NMR trades at a lower P/E of 11.8x. NMR earns a higher WallStSmart Score of 70/100 (B-).

MRX

Strong Buy

68

out of 100

Grade: B-

Growth: 10.0Profit: 6.5Value: 6.0Quality: 3.8
Piotroski: 3/9Altman Z: 0.86

NMR

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 7.7Quality: 3.5
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MRX4 strengths · Avg: 9.3/10
Revenue GrowthGrowth
55.1%10/10

Revenue surging 55.1% year-over-year

EPS GrowthGrowth
55.4%10/10

Earnings expanding 55.4% YoY

Return on EquityProfitability
29.1%9/10

Every $100 of equity generates 29 in profit

P/E RatioValuation
14.1x8/10

Attractively priced relative to earnings

NMR4 strengths · Avg: 9.0/10
P/E RatioValuation
11.8x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

PEG RatioValuation
0.828/10

Growing faster than its price suggests

Revenue GrowthGrowth
27.5%8/10

Revenue surging 27.5% year-over-year

Areas to Watch

MRX2 concerns · Avg: 2.5/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
0.862/10

Distress zone — elevated risk

NMR4 concerns · Avg: 2.3/10
EPS GrowthGrowth
4.5%4/10

4.5% earnings growth

Free Cash FlowQuality
$-1.20T2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
4.671/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : MRX

The strongest argument for MRX centers on Revenue Growth, EPS Growth, Return on Equity. Revenue growth of 55.1% demonstrates continued momentum.

Bull Case : NMR

The strongest argument for NMR centers on P/E Ratio, Price/Book, PEG Ratio. Profitability is solid with margins at 16.7% and operating margin at 18.7%. Revenue growth of 27.5% demonstrates continued momentum.

Bear Case : MRX

The primary concerns for MRX are Piotroski F-Score, Altman Z-Score.

Bear Case : NMR

The primary concerns for NMR are EPS Growth, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.67 is elevated, increasing financial risk.

Key Dynamics to Monitor

NMR carries more volatility with a beta of 0.61 — expect wider price swings.

MRX is growing revenue faster at 55.1% — sustainability is the question.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (70/100 vs 68/100), backed by strong 16.7% margins and 27.5% revenue growth. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Marex Group plc Ordinary Shares

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Marex Group plc is a leading global commodities brokerage and risk management firm that offers comprehensive trading, clearing, and advisory services across vital sectors, including metals, energy, and agricultural commodities. Leveraging cutting-edge technology and extensive market expertise, Marex delivers tailored solutions to a wide range of clients, from multinational corporations to financial institutions and hedge funds. As a publicly traded company, Marex is committed to operational excellence and strategic growth, aiming to strengthen its competitive position in the commodities trading sector while generating sustainable value for its shareholders.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?